A comparison of adherence rates to ritonavir (soft-gel capsules) and its accompanying protease inhibitor (PI) in patients receiving ritonavir boosted PI regimens
Phase of Trial: Phase IV
Latest Information Update: 02 May 2018
At a glance
- Drugs Ritonavir (Primary) ; HIV protease inhibitors
- Indications HIV infections
- Focus Therapeutic Use
- 25 Apr 2018 Status changed from active, no longer recruiting to completed.
- 10 Nov 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 17 Mar 2007 New trial record.